Immune recognition and immunotherapy in hematological malignancies

被引：0
|
作者：
Orsini, E
Guarini, A
Torelli, G
Foá, R
机构：
[1] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy
[2] Univ Turin, Dipartimento Sci Biomed & Oncol Umana, Turin, Italy
来源：
MINERVA BIOTECNOLOGICA | 1999年 / 11卷 / 04期
关键词：
immunotherapy; immunorecognition; immunoplasty; hematological neoplasms;
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
In the present review, we shall discuss how immunotherapy has, over the last 15 years, become a prominent part of the therapeutic armamentarium for different types of hematological malignancies. We will also focus on new prospects in rapid and promising development, as well as on possibilities of inducing immune-mediated recognition of leukemia and lymphoma cells.
引用
收藏
页码：325 / 334
页数：10
相关论文
共 50 条
  • [1] Immune recognition of malignancies: Relevance to immunotherapy
    Nabel, GJ
    CANCER JOURNAL, 1998, 4 : S106 - S111
  • [2] Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
    Einsele, Hermann
    Briones, Javier
    Ciceri, Fabio
    Garcia-Cadenas, Irene
    Falkenburg, Fred
    Bolanos, Natacha
    Heemskerk, H. M. Mirjam
    Houot, Roch
    Hudecek, Michael
    Locatelli, Franco
    Morgan, Kate
    Morris, C. Emma
    O'Dwyer, Michael
    Gil, Jordi Sierra
    van den Brink, Marcel
    van de Loosdrecht, Arjan A.
    HEMASPHERE, 2020, 4 (04):
  • [3] Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
    Anvari, Samira
    Nikbakht, Mohsen
    Vaezi, Mohammad
    Amini-Kafiabad, Sedigheh
    Ahmadvand, Mohammad
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [4] Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
    Antonio Tapia-Galisteo
    Luis Álvarez-Vallina
    Laura Sanz
    Journal of Hematology & Oncology, 16
  • [5] Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
    Tapia-Galisteo, Antonio
    alvarez-Vallina, Luis
    Sanz, Laura
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [6] Cellular immunotherapy for refractory hematological malignancies
    John L Reagan
    Loren D Fast
    Howard Safran
    Martha Nevola
    Eric S Winer
    Jorge J Castillo
    James N Butera
    Matthew I Quesenberry
    Carolyn T Young
    Peter J Quesenberry
    Journal of Translational Medicine, 11
  • [7] Cellular immunotherapy for refractory hematological malignancies
    Reagan, John L.
    Fast, Loren D.
    Safran, Howard
    Nevola, Martha
    Winer, Eric S.
    Castillo, Jorge J.
    Butera, James N.
    Quesenberry, Matthew I.
    Young, Carolyn T.
    Quesenberry, Peter J.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [8] Immunotherapy of hematological malignancies with dendritic cells
    Falkenburg, JHF
    HEMATOLOGY JOURNAL, 2004, 5 : S96 - S99
  • [9] Editorial: Immunotherapy for hematological malignancies in children
    Zhou, Yusi
    Su, Yang
    Xu, Yutong
    Shi, Ming
    FRONTIERS IN PEDIATRICS, 2023, 11
  • [10] Immunotherapy of hematological malignancies:: what is new?
    Ortín, M
    ANNALS OF ONCOLOGY, 2005, 16 : 53 - 62
12345